Clinical Trials

Quantify Motor Symptoms for Clinical Trials

Kinesia technology provides tools to objectively assess Parkinson’s motor symptoms for clinical trials. The system includes a web application for defining studies and viewing reports, as well as a patient kit integrated with broadband for quantitative motor assessment. Kinesia assesses tremor, measures bradykinesia, and quantifies dyskinesia in Parkinson’s for clinical trials. Patients complete automated, video-guided motor assessments at home or in the clinic and the resulting data is uploaded to a secure online server.FDA cleared to market


Telemedicine to Assess Tremor, Bradykinesia, and Dyskinesia